 Hey guys, how you doing? This is your boy, Rich from Rich TV Live and you too can join the club at richpicksdaily.com where you can learn how to win and trade. Hey guys, how you doing? This is your boy, Rich from Rich TV Live and we just launched a new website, a social media community for investors, buy investors, just go to richtv.io, learn how to trade and find winning picks like Numinous Wellness, N-U-M-I in Canada, N-U-M-I-F in America. Put on your radar, put on your watch list, big breaking news exclusively here with your boy, Rich. Let's take a look at this news, shall we? All right, so this is the big news, Numinous Wellness, N-U-M-I in Canada, N-U-M-I-F in America under the OTCQX exchange on the TSX in Canada, a mental, this is a company that is focused on mental healthcare. It's a mental healthcare company advancing innovative treatments and safe evidence-based psychedelic assisted therapies is pleased to announce it has advanced to the next implementation phase in the clinical trial, a multi-site open label extension study of MDMA assisted psychotherapy for PTSD at MAP-USX sponsored by the Multidisciplinary Association for Psychedelic Studies. That's right, psychedelic studies. Now, I think it's important that everybody is aware of their website, it's Numinous.com. And we're going to look at some of the different parts of this news. So, maps, be aware of maps, maps sponsored by the Multidisciplinary Association for Psychedelic Studies, MAPS, and organized by MAPS Public Benefit Corporation, MAPS PBC. And this is the MAPS website right here. MAPS, as you can see here, is the website and get to know it. And organized by MAPS Public Benefit Corporation, MAPS PBC by enrolling and dosing the first clinical trial volunteer in Canada. Numinous hosts the Canadian sites for MAPS USX through two purpose-driven clinics located in Montreal and Vancouver. This week, the Montreal site began drug administration led by trial co-therapists, Dr. Joe Flanders, VP Psychology, Numinous, and Dr. Emma Habke, staff psychiatrist, University Health Network, and principal investigator for the MAPS sponsored trial. The treatments follows MAPS protocol of three sessions of MDMA administration and therapy, each to be followed by three integration sessions. The full program is expected to complete in mid-summer 2022. Numinous is excited to administer the first MDMA assisted therapy dosing of MDMA at our clinics and contribute to the growing body of MAPS research, says Dr. Flanders, designed with accessibility and ethics at its core. We look forward to the continuation of this study and translating the findings into clinical practice. So love to know what you guys think of this news. MAP-USX is an extension of the parent study MAP-1 by MAPS, which investigated the safety of MDMA assisted therapy for treating severe PTSD. The trial is open to those participants from MAP-1 who were enrolled in the placebo arm or could not receive treatment due to COVID restrictions and the resulting data will. So this is the MAPS website and this is the Numinous website. You can see the world has changed and so has mental health care. And I'm gonna go through the chart and I really believe that this could potentially be very undervalued, very underappreciated and extremely under-exposed. You can see the services here for Numinous, ketamine therapy, psychotherapy, psychedelic integration, clinical trials, just to name some of the focuses for Numinous.com. And you can see here a global leader in analytical testing, research and development company that has got their hands in so many places that can literally change the world. We are proud of our clinical and research teams who have been, and then this is something that, you need to be proud of the work you do. So they are proud of their clinical and research teams who have been and continue to be instrumental in driving MDMA assisted therapy for PTSD research forward in Canada, said Peyton Nybkist, who we've had on our show numerous times CEO and founder of Numinous. Today trial progress in another step in our strengthening collaboration with MAPS as we work together to make psychedelic assisted therapy accessible to those in need. We will continue to work with MAPS, Health Canada and the industry to help make MDMA assisted therapy a reality. So you can also stay in the loop here. You can enter in your email and join their mailing list which I've done and you can follow them on social media. I'm gonna show you how I do that. I think it's important to do that. Here is them on LinkedIn. You can see that I'm following them on LinkedIn and this is them on Twitter. You can see I am following them on Twitter. This is their Instagram page. I follow them as well on Instagram so I can stay up to date on everything that is happening with Numinous wellness. Now a little bit about Numinous wellness and I'm gonna also show you guys their chart. This is their Facebook and a little bit about their chart. So I just feel like it's very undervalued at these levels as a company with money in the bank and a company that I think has a very nice position in the psychedelic space, despite the fact that the stock is down very much so over the last year you can see it's aggressively down over the last year. You can see the trend line has been down, right? So we are definitely in my opinion in a buy zone. I think at these levels are lower. It would be a very good buy for investors. I don't currently own any shares but if I do position myself, I will let you know. I do have exposure to psychedelics with other positions but this is one that I think is extremely undervalued underappreciated, underexposed and I believe there's a big gap to fill here in the market right here for this stock to go back to where it was at its 52 week highs, which is $1.25. There's a huge gap to fill there and a lot of money to potentially be made on this security. Now obviously it's come down so it's very risky but for it to go back to where it was at its peak of last year, there's 142% upside. I can't guarantee it's going to happen but with some of the breakthroughs that they are focused on, the potential is there. So a little bit about numinous wellness and the symbol in America is N-U-M-I-F and you can see here, it looks extremely similar here in America and you can see I've got a little zone here that I kind of, I put out there which I thought was kind of a decent buy zone and you can see it's just living in that zone. So I believe there's a huge gap to fill here. So a little bit about numinous wellness helps people to heal and be well through the development and delivery of innovative mental healthcare and access to safe evidence-based psychedelic assisted therapies. The numinous model and you can go to their website guys at numinous.com like here and learn everything about them, learn about their locations. You can see Vancouver, Montreal and Toronto services. You can see all the different services that they provide, five of them, bioscience and about us to learn more. And once again, the numinous model including psychedelic production, research and clinical care is at the forefront of the transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At numinous, we are leading the integration of psychedelic assist therapies into mainstream clinical practice and building the foundation for a healthier society. Now a little bit about MAPS, the company that they are obviously working very closely with now due to this news founded in 1986, MAPS is a 501C3 nonprofit research and educational organization that develops medical, legal and cultural context for people to benefit from the careful uses of psychedelics and marijuana. MAPS is sponsoring the most advanced psychedelic therapy research in the world, phase three clinical trials of MDMA assisted therapy for PTSD. Since its founding, MAPS has raised over 130 million for psychedelic and marijuana research and education and has earned both the guide star, platinum seal, transparency and a four star rating from charity navigator. So love to know what you guys think about this news. If you like this news, please smash the like button, comment down below, share the video everywhere and subscribe, this is Rich from Rich to be Live and I'm out.